Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors

Julius Strauss, Christopher R. Heery, Jeffrey Schlom, +12

Clinical Cancer Research

Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

Christopher R. Heery, Geraldine O’Sullivan Coyne, Ravi A. Madan, +15

The Lancet Oncology

MedicineJavelin Solid TumorSolid TumoursMetronomic TherapySurgery +4

The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells

Caroline Jochéms, Massimo Fantini, Romaine I. Fernando, +13

Oncotarget

T-regulatory CellImmunologyImmune RegulationImmunoeditingImmunotherapeutics +22

Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury

Christopher R. Heery, B. Harpreet Singh, Myrna Rauckhorst, +9

Cancer Immunology Research

ImmunologyImmunoeditingPathologyImmunotherapyTumor Biology +14

Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer

Christopher R. Heery, Nuhad K. Ibrahim, Philip M. Arlen, +14

JAMA Oncology

Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody

Renee N. Donahue, Lauren M. Lepone, Italia Grenga, +6

Journal for ImmunoTherapy of Cancer

Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab

Vincenzo Formica, Raffaele Palmirotta, Girolamo Del Monte, +7

International Journal of Colorectal Disease

MedicinePathologyColorectal CancerPredictive ValueVegf Gene Polymorphisms +3

Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines

Benedetto Farsaci, Renee N. Donahue, Michael A. Coplin, +4

Cancer Immunology Research

Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury

Christopher R. Heery, Claudia Palena, Sheri McMahon, +13

Clinical Cancer Research

A fully human IgG1 anti‐PD‐L1 MAb in an <i>in vitro</i> assay enhances antigen‐specific T‐cell responses

Italia Grenga, Renee N. Donahue, Lauren M. Lepone, +2

Clinical & Translational Immunology

ImmunologyAntigen ProcessingCd4 T Cell ResponsesImmunotherapeuticsImmune System +16